Citation: | CAO Su-mei, HUANG Teng-bo, JIAN Shao-wen, . The Relationship between EB Virus ZEBRA/igG Change Regulation and Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 1999, 26(5): 382-384. |
[1] |
Countryman J,et al.Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterge-neous viral DNA.Proc Natl Acad Sci U S A,1985,82(12):4085~4089
|
[2] |
Chevallier GA,et al.Both Epstein-Barr virus(EBV)-encoded trans-acting factors,EB1 and EB2,are required to activate transcription from an EBV early promoter.EMBO J,1986,5(12):3243~3249
|
[3] |
Taylor N,et al.Expression of the BZLF1 latency-disrupting gene differs in standard and defective Epstein-Barr viruses.J Virol,1989,63(4):1721~1728
|
[4] |
Rooney CM,et al.The spliced BZLF1 gene of Epstein-Barr virus(EBV)transactivates an early EBV promoter and induces the virus productive cycle.J Virol,1989,63(7):3109~3116
|
[5] |
Irene joab,et al.Detection of anti-Epstein-Barr-virus transactivator (ZEBRA)antibodies in sera from patients with nasopharyngeal carcinoma.Int J Cancer,1991,48:647~649
|
[6] |
Yip TT,et al.A possible prognostic role of immunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA in patients with nasopharyngeal carcinoma.Cancer,1994,74(9):2414~2424
|
[7] |
Brooks L,et al.Epstein-Barr virus latent gene transcription in nasopharyn-geal carcinoma cell:coexpression of EBNA1、LMP1 and LMP2 transcripts J Virol,1992,66(5):2689~2697
|
[8] |
Dominique MR,et al.Qualitative analysis of the Epstein-Barr virus lytic gene in nasopharyneal carcinoma biopsies.Journal of General Virology,1995,76:1401~1408
|
[9] |
黄腾波,等.鼻咽癌优化筛查方案-鼻咽癌的早期检出.癌症,1997,16(4):245~247
|
[10] |
闵华庆,等.EB病毒与鼻咽癌相关的前瞻性研究.癌症,1991,10(5):367~369
|